Pliant Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
331 Oyster Point Boulevard, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 04:21 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report SC 13G Oct 4, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G Report Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G Report SCHEDULE 13G Feb 13, 2024
SC 13G/A Report Feb 9, 2024
SC 13G Report Feb 8, 2024
SC 13G Report Jan 25, 2024
SC 13G Report Mar 20, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report CHI ADVISORS LLC Feb 13, 2023
SC 13G/A Report Feb 9, 2023
SC 13G/A Report SC 13G/A Aug 31, 2022
SC 13G/A Report Aug 10, 2022
SC 13G/A Report Jun 10, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report CHI ADVISORS LLC Feb 11, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report CHI ADVISORS LLC Mar 2, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report SCHEDULE 13G/A Feb 16, 2021
SC 13G Report SC 13G Feb 12, 2021
SC 13G/A Report Feb 8, 2021
SC 13G Report Jul 10, 2020
SC 13G Report SC 13G Jun 15, 2020
SC 13G Report SC 13G Jun 9, 2020